Study: Cholesterol-Lowering Statin Drugs Increase Risk of ALS Lou Gehrig’s DiseaseA recent study connecting increased statin drug use with rising ALS was discussed by Dr. Malcom Kendrick. He had followed earlier similar studies with similar concerns, but this one confirmed Dr. Kendrick’s suspicions. ALS (Amyotrophic lateral sclerosis), is also known as motor neuron disease (MND), or Lou Gehrig’s disease. The study of concern is Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System. It was published by the journal Drug Safety in April of 2018. The researchers at the University of California (San Diego) and Advera Health Analytics, Inc., Santa Rosa, California teamed up to analyze data from the FDA Adverse Event Reporting System (FAERS) to determine what is known as reporting odds ratios (RORs) involving statin drugs users who have reported ALS symptoms. This study, which allegedly had no outside funding, concluded: "These findings extend previous evidence showing that significantly elevated ALS reporting extends to individual statin agents, and add to concerns about potential elevated occurrence of ALS-like conditions in association with statin usage."